IDO1 and non-small cell lung carcinoma: To investigate therapy-induced evolution in NSCLC, Maynard et al. employed single-cell RNA sequencing, uncovering significant upregulation of genes involved in the kynurenine metabolism pathway (IDO1, KYNU, QPRT) in EGFR-TKI-resistant tumors [23].